ArticleMolecular cancer therapeutics2023

Venadaparib Is a Novel and Selective PARP Inhibitor with Improved Physicochemical Properties, Efficacy, and Safety.

Myongjae Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.